Development of the h3n2 influenza microneedle vaccine for cross-protection against antigenic variants

HIGHLIGHTS

• who: Yura Shin from the DepartmentGachon University have published the research: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants, in the Journal: Scientific Reports Scientific Reports
• what: HA content measured by HPLC analysis was comparable to that measured using ELISA, and H3N2 microneedle vaccines could be prepared without the use of a standard antibody.

SUMMARY

To prepare a microneedle vaccine to target a virus that mutates frequently like H3N2, a measurement for the amount of active antigen is required in order to load an accurate predetermined . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.